Opportunity Information: Apply for RFA DK 09 506
Apply for RFA DK 09 506
- The National Institutes of Health in the food and nutrition health sector is offering a public funding opportunity titled "Limited Competition for the Continuation of the Adult Acute Liver Failure Study Group (U01)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research.
- This funding opportunity was created on Jan 7, 2010 and posted on Jan 7, 2010.
- Applicants must submit their applications by Mar 15, 2010. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $10,000,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $600,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Public and State controlled institutions of higher education Private institutions of higher education.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This grant opportunity, titled "Limited Competition for the Continuation of the Adult Acute Liver Failure Study Group (U01)," is a National Institutes of Health (NIH) funding announcement issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The main goal is to support a competing continuation of the Adult Acute Liver Failure Study Group, meaning it is intended to keep an existing, established research effort going rather than launch an entirely new program. The emphasis on "limited competition" signals that eligibility to apply is restricted compared to an open NIH competition, typically because the work is viewed as a continuation of a specific ongoing consortium or coordinated research infrastructure that NIH wants to maintain without broadly recompeting it across all possible applicants.
The award uses the NIH cooperative agreement mechanism, specifically the U01. A U01 is different from a standard research project grant because it is designed for situations where NIH expects to have substantial scientific or programmatic involvement during the project. In practice, that generally means the funded group and NIH staff work closely together on elements such as study coordination, protocol development, data standards, milestone tracking, and overall governance. This structure fits large, multi-site clinical research networks and study groups, where maintaining consistent operations, shared data systems, and coordinated decision-making is essential.
NIDDK anticipated making one award under this announcement, with an estimated total of 10,000,000 in funding. The source data also lists an award ceiling of 600,000, which typically reflects a per-year cap or a budget limitation tied to a specific budget period, while the 10 million figure represents the expected total commitment across the full project period. Taken together, the numbers indicate a sizeable, multi-year investment aimed at sustaining the infrastructure and coordinated activities of the Adult Acute Liver Failure Study Group rather than funding a collection of unrelated individual projects.
The opportunity is categorized as discretionary and is associated with a health-related funding activity area, with CFDA number 93.847 (Diabetes, Digestive, and Kidney Diseases Extramural Research). There is no cost sharing or matching requirement, so applicants are not required to contribute non-federal funds as a condition of the award. Eligible applicants include public and state-controlled institutions of higher education and private institutions of higher education, which aligns with the typical institutional base for NIH-supported clinical research consortia and coordinating centers.
Key administrative dates show that the announcement was posted on January 7, 2010, with an application due date (original and current closing date) of March 15, 2010. The archive date is April 15, 2010, meaning it was subsequently closed and stored as a past opportunity. Additional details and the full announcement were made available through the NIH grants guide page linked in the opportunity record. For technical issues accessing the announcement, the contact provided is the NIH Office of Extramural Research (OER) webmaster via FBOWebmaster@OD.NIH.GOV, which is a support contact for access and linking problems rather than a scientific or grants management program contact.
Overall, this FOA represents a targeted NIH investment to continue a coordinated adult acute liver failure research group under a cooperative agreement framework, with a single expected award and a large total funding level intended to sustain and advance the network's collaborative research activities.
Frequently Asked Questions (FAQs)
What is the title of this grant opportunity?
The funding announcement is titled "Limited Competition for the Continuation of the Adult Acute Liver Failure Study Group (U01)."
Which agency and institute are offering this opportunity?
This is a National Institutes of Health (NIH) funding announcement issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
What is the main purpose of this funding announcement?
The main goal is to support a competing continuation of the Adult Acute Liver Failure Study Group. It is intended to continue an existing, established research effort rather than start an entirely new program.
What does "limited competition" mean in this context?
"Limited competition" indicates that eligibility to apply is restricted compared to an open NIH competition. This is typically used when NIH is continuing a specific ongoing consortium or coordinated research infrastructure that it wants to maintain, rather than broadly recompeting it across all possible applicants.
What NIH funding mechanism is used for this award?
The award uses the NIH cooperative agreement mechanism, specifically a U01.
How is a U01 cooperative agreement different from a standard NIH research grant?
A U01 is designed for situations where NIH expects substantial scientific or programmatic involvement during the project. In practice, this generally means the funded group and NIH staff work closely together on areas such as study coordination, protocol development, data standards, milestone tracking, and overall governance.
What types of research efforts does a U01 typically support?
This structure is commonly used for large, multi-site clinical research networks and study groups where consistent operations, shared data systems, and coordinated decision-making are essential.
How many awards did NIDDK anticipate making under this announcement?
NIDDK anticipated making one award under this funding announcement.
What is the estimated total funding level for this opportunity?
The announcement lists an estimated total of 10,000,000 in funding, reflecting the expected total commitment across the full project period.
What is the award ceiling of 600,000 and how does it relate to the total funding amount?
The source data lists an award ceiling of 600,000, which typically reflects a per-year cap or a budget limitation tied to a specific budget period. The 10,000,000 figure represents the anticipated total commitment across the full project period. Together, these numbers suggest a sizable multi-year investment.
Is this opportunity intended to fund multiple unrelated projects?
No. The described funding levels and the continuation focus indicate the investment is aimed at sustaining the infrastructure and coordinated activities of the Adult Acute Liver Failure Study Group rather than funding unrelated individual projects.
What is the funding activity area associated with this opportunity?
The opportunity is associated with a health-related funding activity area.
What is the CFDA number listed for this opportunity?
The CFDA number is 93.847, labeled as Diabetes, Digestive, and Kidney Diseases Extramural Research.
Is cost sharing or matching required?
No. There is no cost sharing or matching requirement, meaning applicants are not required to contribute non-federal funds as a condition of the award.
Which types of organizations are eligible to apply?
Eligible applicants include public and state-controlled institutions of higher education and private institutions of higher education.
When was the funding announcement posted?
The announcement was posted on January 7, 2010.
What was the application due date?
The application due date (original and current closing date) was March 15, 2010.
Is this opportunity still open?
No. The archive date is April 15, 2010, indicating the opportunity was closed and stored as a past opportunity.
Where were additional details and the full announcement provided?
Additional details and the full announcement were made available through the NIH grants guide page linked in the opportunity record.
Who should be contacted for technical issues accessing the announcement?
For technical issues accessing the announcement, the contact provided is the NIH Office of Extramural Research (OER) webmaster at FBOWebmaster@OD.NIH.GOV.
Is the listed email contact a scientific or grants management contact?
No. The provided contact is described as a support contact for access and linking problems rather than a scientific or grants management program contact.
How would you summarize this funding opportunity in plain terms?
This FOA represents a targeted NIH investment to continue a coordinated adult acute liver failure research group under a cooperative agreement (U01) framework, with one expected award and a large total funding level intended to sustain and advance the study group's collaborative research activities.
Browse more opportunities from the same category: Food and Nutrition Health
Next opportunity: Special Research Grants Program Pest Management Alternatives
Previous opportunity: Limited Competition for the Continuation of the Pediatric Acute Liver Failure Study Group (U01)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA DK 09 506
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA DK 09 506) also looked into and applied for these:
| Funding Opportunity |
|---|
| NIDDK Central Repositories Non renewable Sample Access (X01) Apply for PAR 10 090 Funding Number: PAR 10 090 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| NIDDK Education Program Grants (R25) Apply for PAR 10 092 Funding Number: PAR 10 092 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| NIDDK Centers of Excellence in Molecular Hematology (P30) Apply for RFA DK 09 013 Funding Number: RFA DK 09 013 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $750,000 |
| Nutrition Obesity Research Centers (P30) Apply for RFA DK 10 003 Funding Number: RFA DK 10 003 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $750,000 |
| Child Survival Health Grants Program Apply for USAID M OAA GH HSR 10 403 Funding Number: USAID M OAA GH HSR 10 403 Agency: Agency for International Development Category: Food and Nutrition Health Funding Amount: $1,750,000 |
| Grants for Research in Glomerular Diseases (R01) Apply for PA 10 113 Funding Number: PA 10 113 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| Home and Family Based Approaches for the Prevention or Management of Overweight or Obesity in Early Childhood (R21) Apply for PA 10 128 Funding Number: PA 10 128 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $200,000 |
| Home and Family Based Approaches for the Prevention or Management of Overweight or Obesity in Early Childhood (R01) Apply for PA 10 127 Funding Number: PA 10 127 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| Adherence Studies in Adolescents with Chronic Kidney or Urologic Diseases, or Diabetes (R01) Apply for RFA DK 10 004 Funding Number: RFA DK 10 004 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $500,000 |
| Limited Competition for the Continuation of the Consortium for Radiologic Imaging Studies in Polycystic Kidney Disease (CRISP) (U01) Apply for RFA DK 10 501 Funding Number: RFA DK 10 501 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $225,000 |
| Ancillary Studies in Immunomodulation Clinical Trials (R01) Apply for RFA AI 10 014 Funding Number: RFA AI 10 014 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $250,000 |
| Limited Competition for the Continuation of the NIDDK Gastroparesis Consortium (U01) Apply for RFA DK 10 502 Funding Number: RFA DK 10 502 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $300,000 |
| NIDDK Multi Center Clinical Study Implementation Planning Grants (U34) Apply for PAR 10 197 Funding Number: PAR 10 197 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| Mouse Metabolic Phenotyping Centers Consortium (U24) Apply for RFA DK 10 006 Funding Number: RFA DK 10 006 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $600,000 |
| Coordinating and Bioinformatics Unit for the Mouse Metabolic Phenotyping Centers and the Diabetic Complications Consortium (U24) Apply for RFA DK 10 007 Funding Number: RFA DK 10 007 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $250,000 |
| NIDDK Centers for Diabetes Translation Research (P30) Apply for RFA DK 10 009 Funding Number: RFA DK 10 009 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $200,000 |
| Planning Grants for Translating Chronic Kidney Disease (CKD) Research into Improved Clinical Outcomes (R34) Apply for RFA DK 10 011 Funding Number: RFA DK 10 011 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| Type I Diabetes Impact Award (DP3) Apply for RFA DK 10 012 Funding Number: RFA DK 10 012 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| Collaborative Studies on The Central Nervous System and Glycemia (R01) Apply for PAS 11 029 Funding Number: PAS 11 029 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| NIDDK Program Project Applications (P01) Apply for PAR 11 043 Funding Number: PAR 11 043 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA DK 09 506", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.